Coronavirus Update: GSK Signs Non-Coronavirus Deal With CureVac On mRNA Vaccines
Plus: Pfizer And BioNTech Strike UK Deal
Deal brings in new funding and commercial partner for CureVac, and gives GSK greater stake in fast-developing mRNA field.
Deal brings in new funding and commercial partner for CureVac, and gives GSK greater stake in fast-developing mRNA field.